Dallah Healthcare Company (4004.SR) SAU

127.30

+0.5(+0.39%)

Updated at December 25 01:17PM

Currency In SAR

Valuation

Market Cap14.62B
Enterprise Value16.48B
P/E Ratio23.96
PEG Ratio11.5
Price/Sales Ratio3.41
Price/Book Ratio3.04
Enterprise/Revenue4.26
Enterprise/EBITDA21.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.16

Management Effectiveness

Return On Assets0.06
Return On Equity0.13

Income Statement

Revenue3.21B
Revenue/Share37.21
Gross Profit1.21B
EBITDA707.61M
Net Income471.2M
Diluted EPS4.83

Balance Sheet

Total Cash153.67M
Total Cash/Share1.52
Total Debt3.36B
Total Debt/Equity0.79
Current Ratio1.28
Book Value Per Share44.56

Price History

52-Week Change-16.47
52-Week High161.2
52-Week Low109
Moving Average 50 Days138.87
Moving Average 200 Days130.74

Statistics

Average Volume70,337
Shares Outstanding101.23M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate2
Trailing Annual Dividend Yield1.58
Payout Ratio0.38
Last Split Factor6:5
Last Split DateSeptember 14, 2020